Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02875002
Title Study of Volasertib and Belinostat in Patients With Relapsed and Refractory Aggressive B-cell and T-cell Lymphomas
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors Yale University

B-cell lymphoma

peripheral T-cell lymphoma

mantle cell lymphoma

diffuse large B-cell lymphoma

Burkitt lymphoma


Belinostat + Volasertib

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.